Overview

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.

Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This study compares two oral medications (tranexamic acid and aminocaproic acid) as hemostatic agent administered in patients undergoing total knee replacement.
Phase:
Phase 2
Details
Lead Sponsor:
Universidad Autonoma de Nuevo Leon
Treatments:
Aminocaproic Acid
Tranexamic Acid